The North West Fund backs Diagnostic Healthcare

The North West Fund for Biomedical is managed by healthcare-focused venture investor Spark Impact. The fund is a part of the wider £155m North West Fund, financed jointly by the European Regional Development Fund and the European Investment Bank.

The addition of Diagnostic Healthcare to Spark's biomedical portfolio is the fund's 34th investment to date.

The fresh capital will be used to help Diagnostic Healthcare expand its services, increase community services in more locations across the country and expand its portfolio of medical equipment.

Company
Diagnostic Healthcare, headquartered in Altrincham, has a network of centres and mobile units across the UK providing MRI scans, obstetric ultrasound, bone density scans, cardiac testing, health screening and reporting services.

The company provides end-to-end integrated solutions, either as mobile services or located within hospitals, GP surgeries or dedicated community sites.

Diagnostic Healthcare has provided diagnostic services in the UK and abroad for 20 years.

People
Penny Attridge is a senior investment director at Spark Impact and manager of The North West Fund for Biomedical. Liat Karni is managing director of Diagnostic Healthcare, while Michael Ringart is chairman.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Expansion
• Healthcare
• Now researching
• United Kingdom